Ask a question about this product
August 2016 R&D and Business Tracker for Bispecific Antibodies
This pdf report contains information about Bispecific Antibodies released during the month of August 2016. Featured presentations of August 2016 include the pipeline of VEGF-targeted bispecific antibodies, the profile of Dutch biotech company Merus and the technology profile of BEAT bispecific antibodies from Glenmark Pharmaceuticals.
The August 2016 issue of our R&D and Business Tracker service about Bispecific Antibodies covers;
- T-Cell redirecting bispecific cancer antibodies
- NK cell redirecting bispecific cancer antibodies
- Bispecific immuno-oncology antibodies
- Bispecific tumor antigens targeted cancer antibodies
- Bispecific antibodies for inflammatory & autoimmune diseases
- Bispecific antibodies for cardiometabolic, infectious, neurologic, ophthalmic or pulmonary diseases
The monthly update report about Bispecific Antibodies contains:
R&D and Technology Tracker
- Pipeline changes
- Regulatory news
- Technology validations
Business Tracker for:
- Company updates
- Merger & acquisitions
Clinical Trial Tracker
Scientific Publication Tracker
Featured Bispecific Technology Profile: BEAT
Featured Company Profile: Merus
Featured Target or Technology Pipeline: VEGF(-R)-targeted Bispecific Antibodies
Information released during the previous month is retrieved from a variety of sources including corporate press releases and statements, quarterly company business reports, SEC filings, company presentations, company websites, interviews, webcasts, journal articles, scientific abstracts and reviews, relevant scientific meetings, clinical trial databases, and La Merie Publishing’s proprietary database. Relevant information is presented in textual and tabular formats with disclosure of scientific references or by a hyperlink leading to the source of information.
Customized Update Service:
The above described information service represents our standard module. At an incremental cost, the service can be exclusively widened and customized to specific client needs, e.g. preparation of a preferred presentation format, inclusion of a watch list for tracking, executive summary etc.
Contact us at email@example.com to discuss your needs and our ideas of fulfilling them.